Publisher
Springer Nature Singapore
Reference81 articles.
1. Portier CJ (2002) Endocrine dismodulation and cancer. Neuro Endocrinol Lett 23(Suppl 2):43–47
2. Lang-Muritano M, Biason-Lauber A, Gitzelmann C, Belville C, Picard Y, Schoenle EJ (2001) A novel mutation in the anti-müllerian hormone gene as cause of persistent müllerian duct syndrome. Eur J Pediatr 160(11):652–654
3. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR et al (2001) Case-control study of ovarian cancer and polymorphisms in genes involved in catechol estrogen formation and metabolism. Cancer Epidemiol Biomark Prev 10(3):209–216
4. Thomas DB (1983) Factors that promote the development of human breast cancer. Environ Health Perspect 50:209–218
5. Gaido KW, Leonard LS, Lovell S, Gould JC, Babaï D, Portier CJ et al (1997) Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol 143(1):205–212